CUE-101

· Cue Biopharma

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CUE-101, covering 2026-02-06 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: CUE-101with Pembrolizumab for LA-HPV+HNSCCs [Phase 2]